Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 6 Breast Neoplasms 4 Esophageal Squamous Cell Carcinoma 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Locally Advanced Gastric Cancer 2 Colorectal Neoplasms 2 Cervical Cancer Metastatic 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Rectal Cancer Patients 1 Rare Tumour 1 Non-squamous Non-small Cell Lung Cancer 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Liposarcoma 1 Laryngeal Neoplasms 1 Esophageal Squamour Cell Cancer 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Triple Negative Breast Cancer 1 Advanced Pancreatic Cancer 1

Interventions

Paclitaxel 8 Carboplatin 7 Tirzepatide 3 Observation 3 Cisplatin 3 pembrolizumab 2 dostarlimab 2 Megestrol Acetate 2 Medroxyprogesterone Acetate 2 Blood Specimen Collection 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sintilimab 1 semaglutide 1 olaparib 1 montelukast 1 inavolisib 1 enfortumab vedotin 1 ceralasertib 1 camrelizumab 1 apatinib 1 anlotinib 1 Watchful Waiting 1 Vaginal Smears 1 Topotecan 1 Tablets 1 Specimen Handling 1 Sensitivity Training Groups 1 Resistance Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Endometrial Neoplasms × camrelizumab × Clear all

NCT05550558 2022-09-28

CAN-RESPOND

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡